Corcept Therapeutics (CORT) Net Income (2010 - 2026)
Corcept Therapeutics (CORT) recorded Net Income of $42.99 million in Q2 2026, up 22.1% from $35.19 million a year earlier.
Corcept Therapeutics (CORT) Net Income (2010 - 2026) Analysis & Trends
On a TTM basis, Corcept Therapeutics' Net Income came in at $55.23 million as of Jun 30, 2026, down 58.7% year-over-year; for FY2025, it was $99.65 million, down 29.4% from FY2024.
- Annual Net Income has a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
- Across earlier years, Net Income came in at $141.21 million in FY2024 (+33.0%), $106.14 million in FY2023 (+4.7%), $101.42 million in FY2022 (-9.9%) and $112.51 million in FY2021 (+6.1%).
- The Q2 2026 figure is the highest quarterly Net Income since Q3 2024.
- On a year-over-year basis, Net Income rose in two of the last seven quarters, with an average decline of 5.1%.
- Peak year-over-year performance for Net Income in the last five years was growth of 89.1% in Q4 2023, against a decline of 58.3% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -$31.72 million (Q1 2026), $24.29 million (Q4 2025) and $19.67 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Corcept Therapeutics | 12.40 Bn | 10.96 Bn | 252.09 Mn | 42.99 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.99 Mn |
| Mar 31, 2026 | -31.72 Mn |
| Dec 31, 2025 | 24.29 Mn |
| Sep 30, 2025 | 19.67 Mn |
| Jun 30, 2025 | 35.19 Mn |
| Mar 31, 2025 | 20.55 Mn |
| Dec 31, 2024 | 30.78 Mn |
| Sep 30, 2024 | 47.21 Mn |
| Jun 30, 2024 | 35.49 Mn |
| Mar 31, 2024 | 27.76 Mn |
| Dec 31, 2023 | 31.39 Mn |
| Sep 30, 2023 | 31.38 Mn |
| Jun 30, 2023 | 27.53 Mn |
| Mar 31, 2023 | 15.83 Mn |
| Dec 31, 2022 | 16.60 Mn |
| Sep 30, 2022 | 34.61 Mn |
| Jun 30, 2022 | 27.36 Mn |
| Mar 31, 2022 | 22.75 Mn |
| Dec 31, 2021 | 32.05 Mn |
| Sep 30, 2021 | 30.47 Mn |
Corcept Therapeutics Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=CORT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();